Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Oncology Letters
      • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Biomedical Reports
      • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • Information for Authors
    • Information for Reviewers
    • Information for Librarians
    • Information for Advertisers
    • Conferences
  • Language Editing
Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • For Authors
    • For Reviewers
    • For Librarians
    • For Advertisers
    • Conferences
  • Language Editing
Login Register Submit
  • This site uses cookies
  • You can change your cookie settings at any time by following the instructions in our Cookie Policy. To find out more, you may read our Privacy Policy.

    I agree
Search articles by DOI, keyword, author or affiliation
Search
Advanced Search
presentation
International Journal of Molecular Medicine
Join Editorial Board Propose a Special Issue
Print ISSN: 1107-3756 Online ISSN: 1791-244X
Journal Cover
December-2014 Volume 34 Issue 6

Full Size Image

Sign up for eToc alerts
Recommend to Library

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

Medicine International

An International Open Access Journal Devoted to General Medicine.

Journal Cover
December-2014 Volume 34 Issue 6

Full Size Image

Sign up for eToc alerts
Recommend to Library

  • Article
  • Citations
    • Cite This Article
    • Download Citation
    • Create Citation Alert
    • Remove Citation Alert
    • Cited By
  • Similar Articles
    • Related Articles (in Spandidos Publications)
    • Similar Articles (Google Scholar)
    • Similar Articles (PubMed)
  • Download PDF
  • Download XML
  • View XML
Article Open Access

Zinc finger protein 382 is downregulated by promoter hypermethylation in pediatric acute myeloid leukemia patients

  • Authors:
    • Yan-Fang Tao
    • Shao-Yan Hu
    • Jun Lu
    • Lan Cao
    • Wen-Li Zhao
    • Pei-Fang Xiao
    • Li-Xiao Xu
    • Zhi-Heng Li
    • Na-Na Wang
    • Xiao-Juan Du
    • Li-Chao Sun
    • He Zhao
    • Fang Fang
    • Guang-Hao Su
    • Yan-Hong Li
    • Yi-Ping Li
    • Yun-Yun Xu
    • Jian Ni
    • Jian Wang
    • Xing Feng
    • Jian Pan
  • View Affiliations / Copyright

    Affiliations: Department of Hematology and Oncology, Children's Hospital of Soochow University, Suzhou, Jiangsu, P.R. China, Department of Gastroenterology, The 5th Hospital of Chinese PLA, Yinchuan, Ningxia, P.R. China, Department of Cell and Molecular Biology, Cancer Institute (Hospital), Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing, P.R. China, Translational Research Center, Second Hospital, The Second Clinical School, Nanjing Medical University, Nanjing, Jiangsu, P.R. China
    Copyright: © Tao et al. This is an open access article distributed under the terms of Creative Commons Attribution License [CC BY_NC 3.0].
  • Pages: 1505-1515
    |
    Published online on: October 13, 2014
       https://doi.org/10.3892/ijmm.2014.1966
  • Expand metrics +
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
Cited By (CrossRef): 0 citations Loading Articles...

This article is mentioned in:



Abstract

Acute myeloid leukemia (AML) is the second-most common form of leukemia in children. Aberrant DNA methylation patterns are characteristic of AML. Zinc finger protein 382 (ZNF382) has been suggested to be a tumor suppressor gene possibly regulated by promoter hypermethylation in various types of human cancer. However, ZNF382 expression and methylation status in pediatric AML is unknown. In the present study, ZNF382 transcription levels were evaluated by quantitative reverse-transcription PCR. Methylation status was investigated by methylation-specific (MSP) PCR and bisulfate genomic sequencing (BGS). The prognostic significance of ZNF382 expression and promoter methylation was assessed in 105 cases of pediatric AML. The array data suggested that the ZNF382 promoter was hypermethylated in the AML cases examined. MSP PCR and BGS analysis revealed that ZNF382 was hypermethylated in leukemia cell lines. Furthermore, treatment with 5-aza-2'-deoxycytidine (5-Aza) upregulated ZNF382 expression in the selected leukemia cell lines. The aberrant methylation of ZNF382 was observed in 10% (2/20) of the control samples compared with 26.7% (28/105) of the AML samples. ZNF382 expression was significantly decreased in the 105 AML patients compared with the controls. Patients with ZNF382 methylation showed lower ZNF382 transcript levels compared with patients exhibiting no methylation. There were no significant differences in clinical characteristics or cytogenetic analysis between the patients with or without ZNF382 methylation. ZNF382 methylation correlated with minimal residual disease (MRD). Kaplan-Meier survival analysis revealed similar survival times in the samples with ZNF382 methylation, and multivariate analysis revealed that ZNF382 methylation was not an independent prognostic factor in pediatric AML. The epigenetic inactivation of ZNF382 by promoter hypermethylation can be observed in AML cell lines and pediatric AML samples. Therefore, our study suggests that ZNF382 may be considered a putative tumor suppressor gene in pediatric AML. However, further studies focusing on the mechanisms responsible for ZNF382 downregulation in pediatric leukemia are required.
View Figures

Figure 1

Figure 2

Figure 3

Figure 4

View References

1 

Estey E and Dohner H: Acute myeloid leukaemia. Lancet. 368:1894–1907. 2006. View Article : Google Scholar

2 

Wlodarska I, Mecucci C, Baens M, Marynen P and van den Berghe H: ETV6 gene rearrangements in hematopoietic malignant disorders. Leuk Lymphoma. 23:287–295. 1996. View Article : Google Scholar : PubMed/NCBI

3 

Plass C, Oakes C, Blum W and Marcucci G: Epigenetics in acute myeloid leukemia. Semin Oncol. 35:378–387. 2008. View Article : Google Scholar : PubMed/NCBI

4 

Figueroa ME, Lugthart S, Li Y, et al: DNA methylation signatures identify biologically distinct subtypes in acute myeloid leukemia. Cancer Cell. 17:13–27. 2010. View Article : Google Scholar : PubMed/NCBI

5 

Wang N, Pan J, Cao L, et al: The expression and clinical significance of miR-203 in pediatric acute leukemia. Zhonghua Xue Ye Xue Za Zhi. 34:777–781. 2013.(In Chinese).

6 

Jian P, Yan WS, Chao SL, et al: Promoter of TFPI-2 is hypermethylated in Chinese pediatric acute myeloid leukemia. J Pediatr Hematol Oncol. 34:43–46. 2012. View Article : Google Scholar : PubMed/NCBI

7 

Rodrigues EF, Santos-Reboucas CB, Goncalves Pimentel MM, et al: Epigenetic alterations of p15(INK4B) and p16(INK4A) genes in pediatric primary myelodysplastic syndrome. Leuk Lymphoma. 51:1887–1894. 2010. View Article : Google Scholar : PubMed/NCBI

8 

Ekmekci CG, Gutierrez MI, Siraj AK, Ozbek U and Bhatia K: Aberrant methylation of multiple tumor suppressor genes in acute myeloid leukemia. Am J Hematol. 77:233–240. 2004. View Article : Google Scholar : PubMed/NCBI

9 

Britschgi C, Jenal M, Rizzi M, et al: HIC1 tumour suppressor gene is suppressed in acute myeloid leukaemia and induced during granulocytic differentiation. Br J Haematol. 141:179–187. 2008. View Article : Google Scholar : PubMed/NCBI

10 

Voso MT, Scardocci A, Guidi F, et al: Aberrant methylation of DAP-kinase in therapy-related acute myeloid leukemia and myelodysplastic syndromes. Blood. 103:698–700. 2004. View Article : Google Scholar : PubMed/NCBI

11 

Sahu GR, Mishra R, Nagpal JK and Das BR: Alteration of p73 in acute myelogenous leukemia. Am J Hematol. 79:1–7. 2005. View Article : Google Scholar : PubMed/NCBI

12 

Tao YF, Jian N, Jun L, et al: The promoter of miR-663 is hypermethylated in Chinese pediatric acute myeloid leukemia (AML). BMC Med Genet. 14:742013. View Article : Google Scholar : PubMed/NCBI

13 

Paz-Priel I and Friedman A: C/EBPα dysregulation in AML and ALL. Crit Rev Oncog. 16:93–102. 2011.

14 

Tao YF, Pang L, Du XJ, et al: Differential mRNA expression levels of human histone-modifying enzymes in normal karyotype B cell pediatric acute lymphoblastic leukemia. Int J Mol Sci. 14:3376–3394. 2013. View Article : Google Scholar : PubMed/NCBI

15 

Issa JP: CpG island methylator phenotype in cancer. Nat Rev Cancer. 4:988–993. 2004. View Article : Google Scholar : PubMed/NCBI

16 

Boultwood J and Wainscoat JS: Gene silencing by DNA methylation in haematological malignancies. Br J Haematol. 138:3–11. 2007. View Article : Google Scholar : PubMed/NCBI

17 

Gibbons RJ, McDowell TL, Raman S, et al: Mutations in ATRX, encoding a SWI/SNF-like protein, cause diverse changes in the pattern of DNA methylation. Nat Genet. 24:368–371. 2000. View Article : Google Scholar : PubMed/NCBI

18 

Klose RJ and Bird AP: Genomic DNA methylation: the mark and its mediators. Trends Biochem Sci. 31:89–97. 2006. View Article : Google Scholar : PubMed/NCBI

19 

Baylin SB and Ohm JE: Epigenetic gene silencing in cancer - a mechanism for early oncogenic pathway addiction? Nat Rev Cancer. 6:107–116. 2006. View Article : Google Scholar : PubMed/NCBI

20 

Flach J, Dicker F, Schnittger S, et al: An accumulation of cytogenetic and molecular genetic events characterizes the progression from MDS to secondary AML: an analysis of 38 paired samples analyzed by cytogenetics, molecular mutation analysis and SNP microarray profiling. Leukemia. 25:713–718. 2011. View Article : Google Scholar

21 

Gao S, Hsieh CL, Zhou J and Shemshedini L: Zinc Finger 280B regulates sGCα1 and p53 in prostate cancer cells. PLoS One. 8:e787662013.PubMed/NCBI

22 

Wang T, Wang XG, Xu JH, et al: Overexpression of the human ZNF300 gene enhances growth and metastasis of cancer cells through activating NF-κB pathway. J Cell Mol Med. 16:1134–1145. 2012.PubMed/NCBI

23 

Wang Y, Ye X, Zhou J, et al: A novel human KRAB-related zinc finger gene ZNF425 inhibits mitogen-activated protein kinase signaling pathway. BMB Rep. 44:58–63. 2011. View Article : Google Scholar : PubMed/NCBI

24 

Cheng Y, Geng H, Cheng SH, et al: KRAB zinc finger protein ZNF382 is a proapoptotic tumor suppressor that represses multiple oncogenes and is commonly silenced in multiple carcinomas. Cancer Res. 70:6516–6526. 2010. View Article : Google Scholar : PubMed/NCBI

25 

Olek A, Oswald J and Walter J: A modified and improved method for bisulphite based cytosine methylation analysis. Nucleic Acids Res. 24:5064–5066. 1996. View Article : Google Scholar : PubMed/NCBI

26 

Bullinger L, Ehrich M, Dohner K, et al: Quantitative DNA methylation predicts survival in adult acute myeloid leukemia. Blood. 115:636–642. 2010. View Article : Google Scholar : PubMed/NCBI

27 

Deneberg S, Grovdal M, Karimi M, et al: Gene-specific and global methylation patterns predict outcome in patients with acute myeloid leukemia. Leukemia. 24:932–941. 2010. View Article : Google Scholar : PubMed/NCBI

28 

Cancer Genome Atlas Research Network. Genomic and epigenomic landscapes of adult de novo acute myeloid leukemia. N Engl J Med. 368:2059–2074. 2013. View Article : Google Scholar : PubMed/NCBI

29 

Severson PL, Tokar EJ, Vrba L, Waalkes MP and Futscher BW: Coordinate H3K9 and DNA methylation silencing of ZNFs in toxicant-induced malignant transformation. Epigenetics. 8:1080–1088. 2013. View Article : Google Scholar : PubMed/NCBI

30 

Kuang SQ, Tong WG, Yang H, et al: Genome-wide identification of aberrantly methylated promoter associated CpG islands in acute lymphocytic leukemia. Leukemia. 22:1529–1538. 2008. View Article : Google Scholar : PubMed/NCBI

31 

Liu Y, Zhang X, Blumenthal RM and Cheng X: A common mode of recognition for methylated CpG. Trends Biochem Sci. 38:177–183. 2013. View Article : Google Scholar : PubMed/NCBI

32 

Buck-Koehntop BA, Stanfield RL, Ekiert DC, et al: Molecular basis for recognition of methylated and specific DNA sequences by the zinc finger protein Kaiso. Proc Natl Acad Sci USA. 109:15229–15234. 2012. View Article : Google Scholar : PubMed/NCBI

33 

Sasai N, Nakao M and Defossez PA: Sequence-specific recognition of methylated DNA by human zinc-finger proteins. Nucleic Acids Res. 38:5015–5022. 2010. View Article : Google Scholar : PubMed/NCBI

Related Articles

  • Abstract
  • View
  • Download
  • Twitter
Copy and paste a formatted citation
Spandidos Publications style
Tao Y, Hu S, Lu J, Cao L, Zhao W, Xiao P, Xu L, Li Z, Wang N, Du X, Du X, et al: Zinc finger protein 382 is downregulated by promoter hypermethylation in pediatric acute myeloid leukemia patients. Int J Mol Med 34: 1505-1515, 2014.
APA
Tao, Y., Hu, S., Lu, J., Cao, L., Zhao, W., Xiao, P. ... Pan, J. (2014). Zinc finger protein 382 is downregulated by promoter hypermethylation in pediatric acute myeloid leukemia patients. International Journal of Molecular Medicine, 34, 1505-1515. https://doi.org/10.3892/ijmm.2014.1966
MLA
Tao, Y., Hu, S., Lu, J., Cao, L., Zhao, W., Xiao, P., Xu, L., Li, Z., Wang, N., Du, X., Sun, L., Zhao, H., Fang, F., Su, G., Li, Y., Li, Y., Xu, Y., Ni, J., Wang, J., Feng, X., Pan, J."Zinc finger protein 382 is downregulated by promoter hypermethylation in pediatric acute myeloid leukemia patients". International Journal of Molecular Medicine 34.6 (2014): 1505-1515.
Chicago
Tao, Y., Hu, S., Lu, J., Cao, L., Zhao, W., Xiao, P., Xu, L., Li, Z., Wang, N., Du, X., Sun, L., Zhao, H., Fang, F., Su, G., Li, Y., Li, Y., Xu, Y., Ni, J., Wang, J., Feng, X., Pan, J."Zinc finger protein 382 is downregulated by promoter hypermethylation in pediatric acute myeloid leukemia patients". International Journal of Molecular Medicine 34, no. 6 (2014): 1505-1515. https://doi.org/10.3892/ijmm.2014.1966
Copy and paste a formatted citation
x
Spandidos Publications style
Tao Y, Hu S, Lu J, Cao L, Zhao W, Xiao P, Xu L, Li Z, Wang N, Du X, Du X, et al: Zinc finger protein 382 is downregulated by promoter hypermethylation in pediatric acute myeloid leukemia patients. Int J Mol Med 34: 1505-1515, 2014.
APA
Tao, Y., Hu, S., Lu, J., Cao, L., Zhao, W., Xiao, P. ... Pan, J. (2014). Zinc finger protein 382 is downregulated by promoter hypermethylation in pediatric acute myeloid leukemia patients. International Journal of Molecular Medicine, 34, 1505-1515. https://doi.org/10.3892/ijmm.2014.1966
MLA
Tao, Y., Hu, S., Lu, J., Cao, L., Zhao, W., Xiao, P., Xu, L., Li, Z., Wang, N., Du, X., Sun, L., Zhao, H., Fang, F., Su, G., Li, Y., Li, Y., Xu, Y., Ni, J., Wang, J., Feng, X., Pan, J."Zinc finger protein 382 is downregulated by promoter hypermethylation in pediatric acute myeloid leukemia patients". International Journal of Molecular Medicine 34.6 (2014): 1505-1515.
Chicago
Tao, Y., Hu, S., Lu, J., Cao, L., Zhao, W., Xiao, P., Xu, L., Li, Z., Wang, N., Du, X., Sun, L., Zhao, H., Fang, F., Su, G., Li, Y., Li, Y., Xu, Y., Ni, J., Wang, J., Feng, X., Pan, J."Zinc finger protein 382 is downregulated by promoter hypermethylation in pediatric acute myeloid leukemia patients". International Journal of Molecular Medicine 34, no. 6 (2014): 1505-1515. https://doi.org/10.3892/ijmm.2014.1966
Follow us
  • Twitter
  • LinkedIn
  • Facebook
About
  • Spandidos Publications
  • Careers
  • Cookie Policy
  • Privacy Policy
How can we help?
  • Help
  • Live Chat
  • Contact
  • Email to our Support Team